Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

New molecules can prevent cell death in hair follicles.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

BIK1 gene helps plants resist some pathogens but makes them more vulnerable to others.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Upadacitinib may effectively treat resistant lichen planopilaris.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

A new compound shows promise as a topical treatment for hair loss.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Activating PKM2 and Wnt/β-catenin signaling together can potentially enhance hair growth and could be a treatment for hair loss.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Ruxolitinib can cause a delayed skin reaction on the nose.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.